Pain Relief Study Adding Ultrasound-Guided iPACK Block to Adductor Canal Block After Knee Tumor Surgery

What this Trial Is About

Researchers are evaluating the pain relief effects of combining an iPACK block with an Adductor Canal Block ACB after surgery to remove tumors around the knee. The study focuses on measuring the time until the first need for additional pain medication, the amount of morphine used after surgery, and pain levels using the visual analogue scale VAS. This trial includes adult patients aged 18 to 65 years with specific physical health status undergoing knee tumor excision under spinal anesthesia. Participants are randomly assigned to one of two groups. One group receives both the ACB and the iPACK block, where local anesthetic is injected near nerves around the knee using ultrasound guidance. The control group has the ACB area identified by ultrasound but does not receive the nerve block instead, they receive morphine and other pain medications as needed after surgery. Both groups are monitored for pain and medication use following the procedure. During the study, patients will be assessed for pain intensity at multiple time points within 24 hours after surgery and monitored for the time until they request additional pain relief. Morphine consumption and pain scores are recorded to compare the effectiveness of the treatments. Safety and overall recovery progress are observed, and the study is conducted with double-blind methods to reduce bias. Participation lasts through the immediate postoperative period to evaluate early pain management outcomes.

Effect of Adding Ultrasound Guided IPACK Block to Adductor Canal Block for Postoperative Pain in Knee Tumor Excision